Data / Form D filings / ThirdLaw Molecular, Inc.
ThirdLaw Molecular, Inc.: Form D filing
ThirdLaw Molecular, Inc., a biotechnology company in Blue Bell, PA, filed a Form D with the SEC in 2025. The latest, on October 8, 2025, reports $5.5 million sold of a $5.5 million offering to 4 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 512 EAST TOWNSHIP LINE ROAD, 4 VALLEY SQUARE, Blue Bell, PA, 19422
- Phone
- (334) 352-9665
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2024
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2086735
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 8, 2025 | New notice | $5,500,000 | $5,500,000 | 4 | Sep 2, 2025 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Christian Schafmeister | Executive Officer, Director | |
| David Scheer | Director | |
| Brian Halak | Director | |
| Eric Heil | Executive Officer, Director |
Other biotechnology companies in Pennsylvania that filed recently
- BioLattice Ophthalmics, Inc, $1.8 million · Oct 28, 2026
- Myris Therapeutics, Inc. $500,000 · Oct 14, 2026
- Praeventix, Inc. $5.6 million · Sep 10, 2026
- Plowshare Therapies LLC $6.7 million · Aug 31, 2026
- Noveome Biotherapeutics, Inc. $6.8 million · Aug 27, 2026
- AlloTRx Bio Inc. $500,000 · Aug 24, 2026
Every Form D from the week of Oct 6, 2025 · All recent filings in Pennsylvania · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what ThirdLaw Molecular, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.